Citations

Clear

6274 citation(s) found for "To, Andrew".

Autoimmune encephalitis management: MS centers and beyond
Ζεκερίδου, Αναστασία , McKeon, Andrew

Mayo Clinic

Multiple Sclerosis Journal | February 13, 2020 | Volume: 26 | Issue: 13 | Pages: 1618-1626

10.1177/1352458520905485 | PMID 32052703 Get It

Traditionally, multiple sclerosis (MS) specialists have been the go-to providers for managing certain treatable non-demyelinating inflammatory or autoimmune central nervous system (CNS) disorders. The advent of increased incidence (mostly due to improved recognition) prompts the question: who should be managing autoimmune encephalitis? These patients are generally first encountered in the hospital, as well as general neurology and subspecialty clinics, such as epilepsy. Autoimmune neurology is a specialty which gives focus to evaluation and treatment of patients with autoimmune encephalitis, among other disorders, and trains neurologists accordingly. Some of those experts are dual trained in both MS and non-MS inflammatory/autoimmune CNS disorders. Many other autoimmune specialists are trained in non-MS care, such as hospital neurology, movement disorders, and epilepsy. General and other subspecialty providers increasingly find the need to be versed in management of autoimmune encephalitis.
Adapting and evaluating a deep learning language model for clinical why-question answering
Wen, Andrew, Elwazir, Mohamed Y, Moon, Sungrim, Fan, Jungwei , Fan, Jungwei , Wen, Andrew, Elwazir, Mohamed Y, Moon, Sungrim

Mayo Clinic

JAMIA Open | February 13, 2020 | Volume: 3 | Issue: 1 | Pages: 16-20

10.1093/jamiaopen/ooz072 | PMID 32607483 Get It

Abstract Objectives To adapt and evaluate a deep learning language model for answering why-questions based on patient-specific clinical text. Materials and Methods Bidirectional encoder representations from transformers (BERT) models were trained with varying data sources to perform SQuAD 2.0 style why-question answering (why-QA) on clinical notes. The evaluation focused on: (1) comparing the merits from different training data and (2) error analysis. Results The best model achieved an accuracy of 0.707 (or 0.760 by partial match). Training toward customization for the clinical language helped increase 6% in accuracy. Discussion The error analysis suggested that the model did not really perform deep reasoning and that clinical why-QA might warrant more sophisticated solutions. Conclusion The BERT model achieved moderate accuracy in clinical why-QA and should benefit from the rapidly evolving technology. Despite the identified limitations, it could serve as a competent proxy for question-driven clinical information extraction.
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk
Khankari, Nikhil K. , Banbury, Barbara L. , Borges, Maria Carolina , Haycock, Philip , Arndt, Volker , Berndt, Sonja I. , Brenner, Hermann , Casey, Graham , Chang‐Claude, Jenny , Conti, David V. , English, Dallas R. , Figueiredo, Jane C. , Giovannucci, Edward L. , Gunter, Marc J. , Hampe, Jochen , Hoffmeister, Michael , Joshi, Amit D. , Lemire, Mathieu , Li, Li , Lindblom, Annika , Martín, Vicente , Moreno, Vı́ctor , Offit, Kenneth, Rennert, Gad , Schafmayer, Clemens , Schmit, Stephanie L. , Slattery, Martha L. , Thibodeau, Stephen N. , Weinstein, Stephanie J. , Win, Aung Ko , Woods, Michael O. , Wu, Anna H. , Murff, Harvey J. , Gruber, Stephen B. , Peters, Ulrike , Brenner, Hermann , Borges, Maria C , Arndt, Volker , Brenner, Hermann , Chang-Claude, Jenny , English, Dallas R , Giles, Graham G , Hoffmeister, Michael , Martín, Vicente , Moreno, Victor , Pharoah, Paul D P , Rennert, Gad , Sakoda, Lori C , Slattery, Martha L , Weinstein, Stephanie J , Win, Aung K , Wolk, Alicja , Denny, Joshua C , Gunter, Marc J , Haycock, Philip , Brenner, Hermann , Hampe, Jochen , Conti, David V , Lindblom, Annika , Albanes, Demetrius , Bezieau, Stéphane , Campbell, Peter T. , Chan, Andrew T. , Cotterchio, Michelle , Giles, Graham G. , Hopper, John L. , Jenkins, Mark A. , Marchand, Loı̈c Le , Li, Christopher I , Newcomb, Polly A. , Pharoah, Paul D.P. , Sakoda, Lori C. , Song, Mingyang , Ulrich, Cornelia M. , White, Emily , Wolk, Alicja , Cai, Qiuyin , Denny, Joshua C. , Edwards, Todd L. , Zheng, Wei

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | February 12, 2020 | Volume: 29 | Issue: 4 | Pages: 860-870

10.1158/1055-9965.epi-19-0891 | PMID 32051193 Get It

Abstract Background: Results from epidemiologic studies examining polyunsaturated fatty acids (PUFA) and colorectal cancer risk are inconsistent. Mendelian randomization may strengthen causal inference from observational studies. Given their shared metabolic pathway, examining the combined effects of aspirin/NSAID use with PUFAs could help elucidate an association between PUFAs and colorectal cancer risk. Methods: Information was leveraged from genome-wide association studies (GWAS) regarding PUFA-associated SNPs to create weighted genetic scores (wGS) representing genetically predicted circulating blood PUFAs for 11,016 non-Hispanic white colorectal cancer cases and 13,732 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). Associations per SD increase in the wGS were estimated using unconditional logistic regression. Interactions between PUFA wGSs and aspirin/NSAID use on colorectal cancer risk were also examined. Results: Modest colorectal cancer risk reductions were observed per SD increase in circulating linoleic acid [ORLA = 0.96; 95% confidence interval (CI) = 0.93–0.98; P = 5.2 × 10−4] and α-linolenic acid (ORALA = 0.95; 95% CI = 0.92–0.97; P = 5.4 × 10−5), whereas modest increased risks were observed for arachidonic (ORAA = 1.06; 95% CI = 1.03–1.08; P = 3.3 × 10−5), eicosapentaenoic (OREPA = 1.04; 95% CI = 1.01–1.07; P = 2.5 × 10−3), and docosapentaenoic acids (ORDPA = 1.03; 95% CI = 1.01–1.06; P = 1.2 × 10−2). Each of these effects was stronger among aspirin/NSAID nonusers in the stratified analyses. Conclusions: Our study suggests that higher circulating shorter-chain PUFAs (i.e., LA and ALA) were associated with reduced colorectal cancer risk, whereas longer-chain PUFAs (i.e., AA, EPA, and DPA) were associated with an increased colorectal cancer risk. Impact: The interaction of PUFAs with aspirin/NSAID use indicates a shared colorectal cancer inflammatory pathway. Future research should continue to improve PUFA genetic instruments to elucidate the independent effects of PUFAs on colorectal cancer.
Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology
DeStephano, Christopher C. , Kaunitz, Andrew M., Ridgeway, Jennifer L. , Ridgeway, Jennifer L , DeStephano, C C , Bakkum‐Gamez, Jamie N. , Sherman, Mark E.

Mayo Clinic

Cancer Prevention Research | February 11, 2020 | Volume: 13 | Issue: 7 | Pages: 563-568

10.1158/1940-6207.capr-19-0556 | PMID 32047026 Get It

AbstractAlthough endometrial cancer is often diagnosed at an early curable stage, the incidence and mortality from endometrial cancer is rising and minority women are particularly at risk. We hypothesize that delays in clinical presentation contribute to racial disparities in endometrial cancer mortality and treatment-related morbidity. Improved methods for endometrial cancer risk assessment and distinguishing abnormal uterine bleeding and postmenopausal bleeding from physiologic variation are needed. Accordingly, we propose a multipronged strategy that combines innovative patient education with novel early detection strategies to reduce health impacts of endometrial cancer and its precursors, especially among Black women. Futuristic approaches using gamification, smartphone apps, artificial intelligence, and health promotion outside of the physical clinic hold promise in preventing endometrial cancer and reducing morbidity and mortality related to the disease, but they also raise a number of questions that will need to be addressed by future research.
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant–Associated Anaplastic Large-Cell Lymphoma
Ashar, Binita S., Clemens, Mark W. , Miranda, Roberto N. , Sohani, Aliyah R. , Stenzel, Timothy T. , Yoon, Sung Woon , Miranda, Roberto N , Jaffe, Elaine S. , Feldman, Andrew L. , Gaulard, Philippe

Mayo Clinic

Journal of Clinical Oncology | February 11, 2020 | Volume: 38 | Issue: 10 | Pages: 1102-1111

10.1200/jco.19.02778 | PMID 32045544 Get It

PURPOSE To provide guidelines for the accurate pathologic diagnosis of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL), the preoperative evaluation of the patient with suspected BIA-ALCL, and the pathologic evaluation of the capsulectomy specimen. METHODS To better inform patients and healthcare providers about BIA-ALCL, we convened to review diagnostic procedures used in the evaluation of patients with suspected BIA-ALCL. We focused on the processing of the seroma fluid/effusion surrounding the implant, the handling of capsulectomy specimens following removal of implant(s), and the preoperative evaluation of the patient with suspected BIA-ALCL. Recommendations were based on the published literature and our experience to optimize procedures to obtain an accurate diagnosis and assess for tumor invasion and the extent of the disease. RECOMMENDATIONS Early diagnosis of BIA-ALCL is important as the disease can progress and deaths have been reported. Because the most common presentation of BIA-ALCL is swelling of the breast with fluid collection, an accurate diagnosis requires cytologic evaluation of the effusion fluid surrounding the affected implant. The first priority is cytocentrifugation and filtration of fresh, unfixed effusion fluid to produce air-dried smears that are stained with Wright-Giemsa or other Romanowsky-type stains. Preparation of a cell block is desirable to allow for hematoxylin and eosin staining and immunohistochemical analysis of formalin-fixed, paraffin-embedded histologic sections. Cell block sections can be used for polymerase chain reaction–based investigation of T-cell receptor gene rearrangement to detect clonality. Fixation and mapping of the capsulectomy specimen to select multiple representative sections are advised to assess for microscopic tumor involvement and capsular invasion. It is appropriate to assess lymph node involvement by excisional biopsy material rather than fine needle aspiration, due to propensity for focal involvement.
The Hydrogel Endovascular Aneurysm Treatment Trial (HEAT): A Randomized Controlled Trial of the Second-Generation Hydrogel Coil
Bendok, Bernard R. , Abi-Aad, Karl R., Ward, Jennifer , Kniss, Jason F , Kwasny, Mary , Rahme, Rudy J. , Aoun, Salah G. , Tecle, Najib E. El , Zammar, Samer G. , Aoun, Rami James N. , Patra, Devi Prasad, Raymond, Jean , Woo, Henry H. , Dabus, Guilherme , Milot, Geneviève , Scott, John A. , DeNardo, Andrew , Investigators, HEAT Study, Lavine, Sean D., Bozorgchami, Hormozd, Veznedaroglu, Erol, Albuquerque, Felipe C. , Fiorella, David, Boulos, Alan S. , Cortes, Maria, Kanaan, Hilal, Jindal, Gaurav , Klucznik, Richard , Kalmes, David, Xavier, Andrew, Hussain, Muhammad , Moran, Christopher J. , Adel, Brian van , Milot, Genevieve, Hirsch, Joshua A , Carpenter, Jeffrey , Powers, Ciarán J. , Luh, George, Tummala, Ramanchandra, Evans, Avery J. , Garg, Ankur, James, Roberts, Sauvageau, Eric , Fields, Jeremy D. , Grobelny, Thomas, Hartman, J., Patra, Devi P. , Bendok, Bernard R , Ward, Jennifer D, Ahmadieh, Tarek Y. El , Ansari, Sameer A. , Fiorella, David , Dabus, Guilherme C. , Almandoz, Josser E Delgado , Dashti, Shervin R , Investigators, HEAT Study, Deshaies, Eric Michael , Fiorella, David, Tawk, Rabih G. , Romero, Charles, Kelly, Michael , Chaudry, Imran , Pandey, Aditya S , Wang, Dennis Y.Q. , Milot, Genevieve, Jabbour, Pascal , Shankar, Jai , Patsalides, Athos T , Lee, Sung , James, Robert F. , Jayaraman, Mahesh V. , Satti, Sudhakar R

Mayo Clinic

Neurosurgery | February 10, 2020 | Volume: 86 | Issue: 5 | Pages: 615-624

10.1093/neuros/nyaa006 | PMID 32078692 Get It

Abstract BACKGROUND Aneurysm recurrence after coiling has been associated with aneurysm growth, (re)hemorrhage, and a greater need for follow-up. The second-generation HydroCoil Embolic System (HES; MicroVention, Inc) consists of a platinum core with integrated hydrogel and was developed to reduce recurrence through enhancing packing density and healing within the aneurysm. OBJECTIVE To compare recurrence between the second-generation HES and bare platinum coil (BPC) in the new-generation Hydrogel Endovascular Aneurysm Treatment Trial (HEAT). METHODS HEAT is a randomized, controlled trial that enrolled subjects with ruptured or unruptured 3- to 14-mm intracranial aneurysms amenable to coiling. The primary endpoint was aneurysm recurrence using the Raymond-Roy scale. Secondary endpoints included minor and major recurrence, packing density, adverse events related to the procedure and/or device, mortality, initial complete occlusion, aneurysm retreatment, hemorrhage from target aneurysm during follow-up, aneurysm occlusion stability, and clinical outcome at final follow-up. RESULTS A total of 600 patients were randomized (HES, n = 297 and BPC, n = 303), including 28% with ruptured aneurysms. Recurrence occurred in 11 (4.4%) subjects in the HES arm and 44 (15.4%) subjects in the BPC arm ( P = .002). While the initial occlusion rate was higher with BPC, the packing density and both major and minor recurrence rates were in favor of HES. Secondary endpoints including adverse events, retreatment, hemorrhage, mortality, and clinical outcome did not differ between arms. CONCLUSION Coiling of small-to-medium aneurysms with second-generation HES resulted in less recurrence when compared to BPC, without increased harm. These data further support the use of the second-generation HES for the embolization of intracranial aneurysms. Video Abstract
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTR
Rocha, Vanderson , Martin, Andrew St., Bashey, Asad, Boumendil, Ariane , Brunstein, Claudio G. , Castagna, Luca , Finel, Hervé , Kenzey, Chantal , Kharfan‐Dabaja, Mohamed A. , Labussière‐Wallet, Hélène , Moraleda, José M. , Pastano, Rocco , Ayoubi, Hanadi R. El, Sureda, Anna , Volt, Fernanda , Yakoub‐Agha, Ibrahim , Zhang, Mei-Jie , Montoto, Silvia , Eapen, Mary , Boumendil, Ariane , Montoto, Silvia , Yakoub-Agha, Ibrahim , Castagna, Luca , Eapen, Mary , Fatobene, Giancarlo , Hamadani, Mehdi , Robinson, Stephen Paul , Dominietto, Alida , Chalandon, Yves , Perales, Miguel‐Angel , Ruggeri, Annalisa , Zhang, Mei‐Jie , Gluckman, Éliane

Mayo Clinic

Journal of Clinical Oncology | February 7, 2020 | Volume: 38 | Issue: 14 | Pages: 1518-1526

10.1200/jco.19.02408 | PMID 32031876 Get It

PURPOSETo compare the outcomes of patients with Hodgkin or non-Hodgkin lymphoma undergoing nonmyeloablative haploidentical or unrelated cord blood (UCB) hematopoietic cell transplantation.PATIENTS AND METHODSWe retrospectively studied 740 patients with Hodgkin lymphoma (n = 283, 38%) and non-Hodgkin lymphoma (n = 457, 62%) age 18-75 years who received transplantations from 2009 to 2016. Data were reported to the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation, Eurocord, or Center for International Blood and Marrow Transplant Research. Of the 526 patients who received haploidentical transplantation, 68% received bone marrow and 32% received peripheral blood. All patients received a uniform transplantation conditioning regimen (2 Gy of total-body irradiation, cyclophosphamide, and fludarabine) and graft-versus-host disease prophylaxis (calcineurin inhibitor and mycophenolate). In addition, patients who received a haploidentical transplantation received posttransplantation cyclophosphamide.RESULTSCompared with haploidentical bone marrow and peripheral-blood transplantations and adjusted for age, lymphoma subtype, and disease status, survival was lower after UCB transplantation (hazard ratio [HR], 1.55; P = .001; and HR, 1.59; P = .005, respectively). Similarly, progression-free survival was lower after UCB transplantations compared with haploidentical bone marrow and peripheral-blood transplantations (HR, 1.44; P = .002; and HR, 1.86; P < .0001), respectively. The 4-year overall and progression-free survival rates after UCB transplantation were 49% and 36%, respectively, compared with 58% and 46% after haploidentical bone marrow transplantation and 59% and 52% after peripheral-blood transplantation, respectively. Lower survival was attributed to higher transplantation-related mortality after UCB transplantation compared with haploidentical bone marrow and peripheral-blood transplantation (HR, 1.91; P = .0001; and HR, 2.27; P = .0002, respectively).CONCLUSIONWhen considering HLA-mismatched transplantation for Hodgkin or non-Hodgkin lymphoma, the data support haploidentical related donor transplantation over UCB transplantation.
Giant Cell Tumor of Bone With Cartilage Matrix
Brčić, Iva , Yamani, Feisal, Inwards, Carrie Y., Sumathi, Vaiyapuri P., Dodd, Leslie G. , Kreiger, Portia A., Sittampalam, Kesavan, Allred, Ted R., Liegl‐Atzwanger, Bernadette , Nielsen, G. Petur , Kashofer, Karl , Kerr, Darcy A. , Rosenberg, Andrew E.

Mayo Clinic

American Journal of Surgical Pathology | February 7, 2020 | Volume: 44 | Issue: 6 | Pages: 748-756

10.1097/pas.0000000000001446 | PMID 32412716 Get It

Giant cell tumor of bone (GCT) is a benign locally aggressive neoplasm composed of mononuclear cells admixed with innumerable osteoclast-type giant cells. H3F3A gene mutations producing mutant histone protein product H3.3 have been identified in 96% of GCT; mutant H3.3 is reliably demonstrated by immunohistochemistry. GCT may contain woven bone and rarely, neoplastic cartilage nodules which causes diagnostic challenges with aggressive neoplasms such as osteosarcoma. We describe the features of GCT with cartilage matrix and report the next-generation sequencing findings in a subset of tumors. Seventeen cases of GCT with cartilage matrix form the cohort: 7 males and 10 females, 13 to 55 (mean: 25) years old. Tumors involved the fibula (6), femur (6), and patella, tibia, humerus, S1, and scapula (1 case each). Tumors were radiolucent, circumscribed, lytic, and expansile. All contained classic GCT, foci of cartilage matrix, and trabeculae of woven bone. Immunohistochemistry showed diffuse staining for H3.3 in 9/9 cases and 1 case was positive for S100 and SOX9 in the cartilage areas. Next-generation sequencing showed a mutation in the H3F3A gene in 6/6 cases. On follow-up, 2 patients who underwent resection showed no disease after 12, and 7 months, respectively. Three patients had recurrences 10, 12, and 27 months after curettage; there were no metastases. GCT with cartilage matrix is uncommon. The cartilage matrix is associated with woven bone suggesting the neoplastic cells may differentiate into chondrocyte-like and osteoblast-like cells. Recognition of this neoplasm is important to prevent misdiagnosis and overtreatment of affected patients.
Signs of Increased Intrapericardial Pressure on Chest Computed Tomography
Rojas, Carlos, Padilla, Gary, Feldhaus, Jacob M., Rajan, Celin, Shapiro, Brian P. , Mergo, Patricia J. , Livingston, David H. , Bowman, Andrew W.

Mayo Clinic

Journal of Thoracic Imaging | February 7, 2020 | Volume: 35 | Issue: 3 | Pages: 143-152

10.1097/rti.0000000000000475 | PMID 32073542 Get It

We sought to describe incidental imaging features of increased intrapericardial pressure due to pericardial effusion on chest computed tomography (CT) and correlate them with cardiac CT, cardiac magnetic resonance imaging, and echocardiography. It is important for the radiologist to become familiar with imaging findings of increased intrapericardial pressure in the setting of pericardial effusion when identified on chest CT. Recognizing the imaging findings of increased intrapericardial pressure can better guide the care of these patients.